A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma
HPB 23 巻 1 号
134-143 頁
2021-01 発行
アクセス数 : 323 件
ダウンロード数 : 69 件
今月のアクセス数 : 11 件
今月のダウンロード数 : 3 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00051516
| ファイル情報(添付) | |
| タイトル ( eng ) |
A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma
|
| 作成者 |
Honmyo Naruhiko
Oshita Akihiko
Onoe Takashi
Kohashi Toshihiko
Fukuda Saburo
Ohmori Ichiro
Abe Tomoyuki
Imaoka Yasuhiro
|
| 収録物名 |
HPB
|
| 巻 | 23 |
| 号 | 1 |
| 開始ページ | 134 |
| 終了ページ | 143 |
| 抄録 |
Background
The permissible liver resection rate for preventing posthepatectomy liver failure (PHLF) remains unclear. We aimed to develop a novel PHLF-predicting model and to strategize hepatectomy for hepatocellular carcinoma (HCC). Methods This retrospective study included 335 HCC patients who underwent anatomical hepatectomy at eight institutions between 2013 and 2017. Risk factors, including volume-associated liver-estimating parameters, for PHLF grade B–C were analyzed in a training set (n = 122) via multivariate analysis, and a PHLF prediction model was developed. The utility of the model was evaluated in a validation set (n = 213). Results Our model was based on the three independent risk factors for PHLF identified in the training set: volume-associated indocyanine green retention rate at 15 min, platelet count, and prothrombin time index (the VIPP score). The areas under the receiver operating characteristic curve of the VIPP scores for severe PHLF in the training and validation sets were 0.864 and 0.794, respectively. In both sets, the VIPP score stratified patients at risk for severe PHLF, with a score of 3 (specificity, 0.92) indicating higher risk. Conclusion Our model facilitates the selection of the appropriate hepatectomy procedure by providing permissible liver resection rates based on VIPP scores. |
| 内容記述 |
This research was supported by the Japan Agency for Medical Research and Development (AMED, grant number JP19fk0210051) and the Japanese Society for the Promotion of Science (JSPS KAKENHI, grant number JP18K08706)
|
| 言語 |
英語
|
| 資源タイプ | 学術雑誌論文 |
| 出版者 |
Elsevier
|
| 発行日 | 2021-01 |
| 権利情報 |
© 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
This is not the published version. Please cite only the published version. この論文は出版社版ではありません。引用の際には出版社版をご確認、ご利用ください。
|
| 出版タイプ | Author’s Original（十分な品質であるとして、著者から正式な査読に提出される版） |
| アクセス権 | オープンアクセス |
| 収録物識別子 |
[ISSN] 1365-182X
[ISSN] 1477-2574
[DOI] 10.1016/j.hpb.2020.05.008
[DOI] https://doi.org/10.1016/j.hpb.2020.05.008
|
